Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL25300656

N#Cc1ccnc(N2CCC(C(=O)O)CC2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.56
CHRM4 P08173 1/20 0.53
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
HRH3 Q9Y5N1 1/20 0.50
LCAT P04180 1/20 0.48
NOTUM Q6P988 1/20 0.48
DPP4 P27487 2/20 0.46
DPP7 Q9UHL4 2/20 0.46
DPP8 Q6V1X1 1/20 0.46
DPP9 Q86TI2 1/20 0.46
THRB P10828 1/20 0.46
ITGB2 P05107 3/20 0.45
ICAM1 P05362 3/20 0.45
ITGAL P20701 3/20 0.45
USP30 Q70CQ3 1/20 0.45
PANK3 Q9H999 1/20 0.44
HCRTR1 O43613 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990732 0.93 MALT1 (0.59) MALT1CHRM4PDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL30338667 0.92 MALT1 (0.52) MALT1CHRM4PDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL1025514 0.85 FFAR4 (0.56) MALT1CHRM4HRH3LCATDPP4
Trifluoroacetic Acid SCHEMBL30338657 0.80 GPR119 (0.54) PDE4APDE4BPDE4CPDE4DNOTUM
Trifluoroacetic Acid SCHEMBL30338868 0.80 DPP4 (0.49) DPP4DPP7DPP8DPP9ITGB2
Acetic Acid SCHEMBL1025513 0.79 HRH3 (0.61) MALT1CHRM4HRH3LCATUSP30
SCHEMBL25818614 0.79 KDM4E (0.58) MALT1CHRM4HRH3THRBUSP30
SCHEMBL5220987 0.77 USP30 (0.57) MALT1CHRM4HRH3LCATDPP4
SCHEMBL13622626 0.77 CHRM4 (0.56) MALT1CHRM4HRH3LCATDPP4
Trifluoroacetic Acid SCHEMBL29048229 0.77 KDM4E (0.52) CHRM4PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116547281-A Isoxazolidines as RIPK1 inhibitors and uses thereof 赛诺菲 2023-08-04 CN disclosed
US-20230219937-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-07-13 US disclosed
EP-4157835-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF SANOFI (FR) 2023-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219937-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF RIPK1, RIPK4, RIPK2 MALT1 813/4885CHRM4 4435/4885PDE4A 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.